Former President Trump has nominated Dr. Heidi Overton, a current White House aide, to become the next commissioner of the Food and Drug Administration (FDA). This nomination fills a key leadership position at the agency responsible for regulating food, drugs, and medical devices. Overton’s selection signals a potential shift in the FDA’s direction under future leadership, though confirmation is still pending. Currently, the FDA is operating with a temporary leader. The role of FDA commissioner is crucial for public health and safety, overseeing billions of dollars in regulated products. Overton’s background and policy stances will likely face scrutiny during the confirmation process. Her appointment requires Senate confirmation before she can officially assume the role.